← All companies
ACH
Accendra Health, Inc.
$3.41
+0.07 +2.10%
Key statistics
from XBRL data in SEC filingsMarket cap
$261M
Revenue (TTM)
$2.72B
Net income (TTM)
-$1.08B
EPS (TTM)
$-14.07
P/E ratio
—
Dividend yield
0.29%
Free cash flow
-$293M
Cash
$337M
Total assets
$2.42B
Gross margin
81.4%
52-week range
$1.84 – $7.10
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jun 25, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Jun 15, 2026
8-K
Regulation FD disclosure
May 22, 2026
8-K
Director or officer change; Shareholder vote results
May 15, 2026
10-Q
Quarter ended 2026-03-31
May 11, 2026
8-K
Entered a material agreement; Regulation FD disclosure
May 11, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 11, 2026
10-K
Fiscal year ended 2025-12-31
Feb 20, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 19, 2026
8-K/A
Jan 5, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Director or officer change; Amended charter or bylaws; Regulation FD disclosure
Dec 31, 2025
8-K
Director or officer change; Regulation FD disclosure
Dec 18, 2025
8-K
Director or officer change; Regulation FD disclosure
Dec 8, 2025
8-K
Regulation FD disclosure
Dec 2, 2025
10-Q
Quarter ended 2025-09-30
Oct 31, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Oct 30, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Oct 7, 2025
8-K
Director or officer change
Sep 19, 2025
10-Q
Quarter ended 2025-06-30
Aug 11, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 11, 2025
8-K
Triggering event accelerating an obligation
Jun 6, 2025
8-K
Entered a material agreement; Terminated a material agreement; Other events
Jun 5, 2025
8-K
Shareholder vote results
May 16, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 8, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Apr 4, 2025
8-K
Regulation FD disclosure
Apr 2, 2025
8-K
Regulation FD disclosure; Other events
Mar 26, 2025
8-K
Regulation FD disclosure
Mar 20, 2025
10-K
Fiscal year ended 2024-12-31
Feb 28, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 28, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 3, 2025
8-K
Director or officer change
Nov 5, 2024
10-Q
Quarter ended 2024-09-30
Nov 4, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 4, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Oct 22, 2024
8-K
Other events
Oct 15, 2024
8-K
Director or officer change
Sep 23, 2024
8-K
Other events
Sep 16, 2024
10-Q
Quarter ended 2024-06-30
Aug 2, 2024